Trademarkia Logo

Canada

C$
Trademark Search in Canada
BILIX

View On IC.GC.CA

BILIX
REGISTERED

on 1 Nov 2023

Last Applicant/ Owned by

BILIX CO. LTD.

12th Fl., 364, Gangnam-daero, Gangnam-guSeoul

KR

Serial Number

2078861 filed on 11th Nov 2020

Registration Number

TMA1205943 registered on 1st Nov 2023

Registration expiry Date

11th Nov 2030

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

BILIX

Trademark usage description

human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; i Read More

Classification Information

Class [005]
Human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations made from human blood cells for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical preparations for the treatment of dermatitis, skin pigmentation diseases and psoriasis; diagnostic preparations for medical laboratory use; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; pharmaceutical preparations for the treatment of dental and oral diseases; intestinal disorder medicine for the treatment of irritable bowel syndrome; ophthalmic preparations; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; human pharmaceutical vaccines; reagents for use in medical testing for COVID-19 and other coronavirus diseases.

Classification kind code

11

Class [042]
Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; providing scientific information in the field of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; medical and pharmacological research services; testing of pharmaceuticals; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; conducting research, development, and evaluations in the field of new pharmaceuticals.

Classification kind code

11

Mark Details

Serial Number

2078861

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 31st Oct 2022		Agent Changed
Submitted for opposition 22
on 10th May 2022		Search Recorded
Submitted for opposition 20
on 10th May 2022		Examiner's First Report
Submitted for opposition 223
on 10th May 2022		Total Provisional Refusal
Submitted for opposition 256
on 22nd Nov 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st Jan 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Jan 2021		Formalized
Submitted for opposition 1
on 20th Jan 2021		Created
Submitted for opposition 228
on 11th Nov 2020		International Registration
Submitted for opposition 30
on 11th Nov 2020		Filed